China's Innovent signs $11.4b cancer therapy deal with Japan's Takeda

A sign stands outside Chinese drugmaker Innovent Biologics' office in Shanghai, China July 11, 2025. REUTERS/Andrew Silver

Printed by Unregistered user on Thu, 18 Dec 2025 15:08:41 GMT